Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury

This publication has 57 references indexed in Scilit:

• Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease
  Proceedings of the National Academy of Sciences, 2006
• Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats
  Kidney International, 2005
• Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
  Blood, 2005
• Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat
  Nephrology Dialysis Transplantation, 2004
• CD44 in Cancer
  Critical Reviews in Clinical Laboratory Sciences, 2002
• Bone marrow contributes to renal parenchymal turnover and regeneration
  The Journal of Pathology, 2001
• Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.
  The Journal of Experimental Medicine, 1992
• CD44 is the principal cell surface receptor for hyaluronate
  Cell, 1990
• Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema.
  The Journal of Experimental Medicine, 1990
• Expression and modulation of surface antigens in cultured rat glomerular visceral epithelial cells.
  Journal of Histochemistry & Cytochemistry, 1989